As we have informed last 15 November 2022 here, Hangzhou GreatStar Industrial, whose A Shares are listed on the Shenzhen Stock Exchange, became the eighth Chinese company that has listed global depositary receipts (GDRs) on the SIX Swiss Exchange. Hangzhou GreatStar Industrial issued and listed 11,812,700 GDRs at an offer price of USD 13.08 per […]
Tags : Vischer
Anokion, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, recently closed an USD 35 million equity investment from Pfizer through the Pfizer Breakthrough Growth Initiative. Founded in Switzerland and based on innovation from the EPFL Life Sciences, Anokion is led by a diverse team of entrepreneurial scientists and experienced […]
Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies, a privately owned Swiss company spun out from EPFL. The financing was realised in form of private bonds with warrants which can be drawn down in multiple tranches. Based in Lausanne, Lunaphore Technologies has developed a game-changing chip technology which can extract […]
Versantis, a private Swiss-based clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases, is to be sold to Genfit. With this acquisition, Genfit intends to expand its product portfolio with a Phase 2 ready programme based on first-in-class scanning liposome technology, a paediatric programme focused on urea cycle disorder […]
VISCHER has advised Forty51 Ventures, a Biotech venture capital firm, on its first fund, Forty51 Ventures Fund I which has raised USD 43 million in a first closing and is domiciled in Luxemburg. VISCHER has supported, in particular, regarding the setting up of Forty51 Advisory, in Basel which renders advisory services to the Fund. As […]
The management of Roventa-Henex has acquired 60% of the share capital of the company. The manufacturer of quality Swiss Made Private Label watches also designs, develops and distributes private label watches and related components. It was founded in 1959 by Norbert Schenkel in Biel. The Munich-based Findos Investor, an independent mid-market private equity fund, retains […]
VISCHER has advised EBL on the sale of its Telekom division to Sunrise. EBL has been active in the telecom business since 2000 and owns telecom networks in around 200 communities in Switzerland. At the same time, EBL has been successfully pursuing a strong expansion of its business with renewable energy, heat production and distribution […]
As we have informed last 28th July, Keda Industrial Group and Ningbo Shanshan were among the first companies which successfully listed global depositary receipts (GDRs) on SIX Swiss Exchange. Keda Industrial Group, whose A shares are listed on the Shanghai Stock Exchange, raised gross proceeds in the amount of approx. USD 173 mio. from the offering of GDRs and Ningbo Shanshan, […]
QoQa Brew, a subsidiary of QoQa Services, has financed its craft brewery through a security token offering. The brewery will be located in the “QG”, a co-working eco-friendly space imagine by QoQa Services, a leading Swiss innovative daily sales website proposing attractive offers to its community. The new building designed by QoQa in Bussigny, the […]
Mosanna Therapeutics, a Basel-based biotechnology company, has closed a Seed Financing Round led by Forty51 Ventures. The proceeds will be used for formulation and manufacturing optimization of the molecule MOS118 and for regulatory activities in preparation of the first Phase 1b clinical trial. Mosanna is developing the advanced small molecule MOS118, formerly know as AVE0118, […]
